我从11月21日开始交易，因为我没有一大笔投资金额。
所以我做的是知道我的目标和我要成为什么样的交易者。
目前，我的股票表现不佳，但我相信这对我作为新手来说是一个好的开始。
我所学到的是，不要被情绪带走。
用闲置现金投资，不要盲目投资。
别发牢骚，不要因为持有一只下跌的股票感到尴尬。

$Altimeter Growth Corp (AGC.US)$
Grab + Mastercard 🤔
https://www.theedgemarkets.com/article/mastercard-grab-bring-digital-upskilling-millions-informal-workers-southeast-asia

$艾伯维公司 (ABBV.US)$ On Oct. 7, AbbVie said top-line results showed Rinvoq (Upadacitinib) met the primary endpoint of two studies that were part of a Phase III SELect-Axis 2 trial testing its oral JAK inhibitor in patients with axial spinal arthritis. Rinvoq is already approved for rheumatoid arthritis in the United States and Europe, and the company has been looking to add more indications to its label and recently filed for use in ulcerative colitis, although the FDA has delayed some decisions as it reviews some safety issues involving JAK inhibitors.